Haleon plc (NYSE:HLN) Receives $10.95 Consensus Price Target from Analysts

Shares of Haleon plc (NYSE:HLN) have received an average rating of “Moderate Buy” from the seven ratings firms that are covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $10.95.

A number of equities research analysts have commented on the stock. Morgan Stanley cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday. UBS Group raised shares of Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Finally, Sanford C. Bernstein downgraded shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th.

Haleon Stock Performance

NYSE:HLN opened at $9.10 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $41.19 billion, a price-to-earnings ratio of 26.76, a PEG ratio of 2.95 and a beta of 0.29. The firm has a fifty day simple moving average of $9.59 and a two-hundred day simple moving average of $9.69. Haleon has a 12 month low of $7.89 and a 12 month high of $10.80.

Institutional Investors Weigh In On Haleon

A number of institutional investors have recently added to or reduced their stakes in HLN. Rhumbline Advisers grew its position in Haleon by 20.0% in the 2nd quarter. Rhumbline Advisers now owns 48,966 shares of the company’s stock worth $404,000 after purchasing an additional 8,160 shares in the last quarter. Caprock Group LLC boosted its stake in Haleon by 21.9% in the second quarter. Caprock Group LLC now owns 53,410 shares of the company’s stock valued at $441,000 after acquiring an additional 9,582 shares during the last quarter. PFG Investments LLC boosted its stake in Haleon by 24.2% in the second quarter. PFG Investments LLC now owns 24,652 shares of the company’s stock valued at $204,000 after acquiring an additional 4,811 shares during the last quarter. Dorsey & Whitney Trust CO LLC boosted its stake in Haleon by 18.4% in the second quarter. Dorsey & Whitney Trust CO LLC now owns 25,595 shares of the company’s stock valued at $211,000 after acquiring an additional 3,985 shares during the last quarter. Finally, BOKF NA boosted its stake in Haleon by 68.8% in the second quarter. BOKF NA now owns 6,972 shares of the company’s stock valued at $58,000 after acquiring an additional 2,842 shares during the last quarter. 6.67% of the stock is owned by institutional investors.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.